Aquilo Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-200,000	Closed	-$17.9M	–	11
2023 Q4	$17.9M	Buy	+200,000	New	+$14.9M	11.13%	6
2023 Q1	–	Sell	-500,000	Closed	-$41.5M	–	13
2022 Q4	$41.5M	Hold	500,000	–	–	15.59%	2
2022 Q3	$39.7M	Sell	500,000 -250,000	-33%	-$21.1M	14.3%	2
2022 Q2	$55.7M	Buy	+750,000	New	+$56.3M	19.01%	1
2021 Q4	–	Sell	-1,000,000	Closed	-$126M	–	15
2021 Q3	$126M	Buy	+1,000,000	New	+$129M	22.83%	1
2021 Q2	–	Sell	-500,000	Closed	-$67.8M	–	17
2021 Q1	$67.8M	Hold	500,000	–	–	12.26%	2
2020 Q4	$70.4M	Sell	500,000 -3,500,000	-88%	-$448M	14.63%	3
2020 Q3	$446M	Buy	4,000,000 +2,000,000	+100%	+$224M	47.19%	1
2020 Q2	$224M	Buy	2,000,000 +1,000,000	+100%	+$98.5M	45.15%	1
2020 Q1	$77.4M	Sell	1,000,000 -250,000	-20%	-$22.1M	30.18%	1
2019 Q4	$119M	Buy	1,250,000 +750,000	+150%	+$64.9M	44.66%	1
2019 Q3	$38.1M	Hold	500,000	–	–	26.85%	1
2019 Q2	$43.9M	Hold	500,000	–	–	15.22%	2
2019 Q1	$45.3M	Sell	500,000 -1,000,000	-67%	-$85.1M	20.04%	2
2018 Q4	$108M	Buy	1,500,000 +400,000	+36%	+$32.2M	52.09%	1
2018 Q3	$105M	Buy	1,100,000 +500,000	+83%	+$48.5M	44.14%	1
2018 Q2	$1.36M	Buy	+600,000	New	+$55.1M	1.12%	12